
Aspire Biopharma is developing next generation absorption of medicine that will have a significant impact on the opioid crisis. Our nano technology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tract. Aspire's technology comes from a new mechanism of action (... Aspire Biopharma is developing next generation absorption of medicine that will have a significant impact on the opioid crisis. Our nano technology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tract. Aspire's technology comes from a new mechanism of action (absorption pathway) which allows for instant absorption in the mouth. Benefits of "instant absorption" are to provide nearly instant treatment impact and also allows high dose absorption. Our technology can be applied to any number of proven drugs and supplements, such as analgesics, erectile dysfunction, and traumatic brain injury drugs. 詳細を表示
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 11.6 | 11.6 | 11.6 | 0 | 0 | CS |
4 | 1.6 | 16 | 10 | 11.6 | 10 | 18 | 11.6 | CS |
12 | -0.4 | -3.33333333333 | 12 | 16.45 | 9.81 | 2442 | 12.57207332 | CS |
26 | 0.2 | 1.75438596491 | 11.4 | 16.45 | 9.81 | 1491 | 12.55376691 | CS |
52 | 0.71 | 6.51974288338 | 10.89 | 16.45 | 9.81 | 805 | 12.48285815 | CS |
156 | 1.58 | 15.7684630739 | 10.02 | 16.45 | 9.81 | 2813 | 10.3879349 | CS |
260 | 1.58 | 15.7684630739 | 10.02 | 16.45 | 9.81 | 22996 | 10.0561328 | CS |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約